A child receives the oral cholera vaccine (OCV) at Minawao Camp for internally displaced people (IDP), Cameroon.
Credit: Gavi/2015/Athanas Makundi.
Geneva, 23 May 2016 - Gavi, the Vaccine Alliance remains committed to working in fragile settings and has increased its focus on the specific challenges they pose through its current Fragility and Immunisation policy.
Approved in 2012, the policy paths the way for flexible and country tailored approaches, in which approximately one third of Gavi funding is invested (nearly US$ 425 million in 2015). Under the terms of this policy, Gavi will continue to provide vaccines to governments for refugees and internally displaced populations in Gavi-supported countries.
In 2016, Gavi has committed to reviewing its response to humanitarian emergencies and fragile settings to ensure that the Alliance’s response is in line with best practices in such environments.
Under Gavi’s 2016-2020 strategy, the Vaccine Alliance has committed to reaching the un-reached with life-saving vaccines and investing in building resilient health systems. This includes investment in national laboratory and surveillance capacity strengthening in line with the core capacities of the international health regulations.
Recognising that outbreaks can create urgent needs with humanitarian consequences, existing efforts such as funding vaccine stockpiles for outbreak response will also continue to be enhanced. For example, Gavi has committed to purchasing the first generation Ebola vaccine for a global stockpile once a vaccine(s) is licensed and WHO recommended.
Gavi will remain committed to innovative engagement with partners and countries to help prepare, detect and respond to disease outbreaks and thereby help protect the health of millions of people including in fragile environments.